Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia

Jung Sook Yeom1, Myung Bum Choi, Ji-Hyun Seo

  • 1Department of Pediatrics, Gyeongsang National University School of Medicine, Gyeongsang Institute of Health Science, Republic of Korea.

Insights

Headache in children with functional dyspepsia is linked to increased mast cells in the stomach and duodenum. This finding may help doctors treat concurrent headaches and dyspeptic symptoms in pediatric patients.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Immunology

Background:

  • Functional dyspepsia (FD) and headache frequently coexist in pediatric patients.
  • Mechanisms linking FD and headache, particularly in Helicobacter pylori-negative cases, are not well understood.
  • This study investigates the role of gastrointestinal inflammatory cells in pediatric FD patients experiencing headaches.

Purpose of the Study:

  • To explore the association between gastroduodenal mucosal inflammatory cells and headache in children with H. pylori-negative functional dyspepsia.
  • To identify potential cellular mechanisms underlying concurrent headache and dyspeptic symptoms.

Main Methods:

  • Fifty-six pediatric patients with H. pylori-negative FD underwent upper endoscopy and biopsy.
  • Patients were grouped based on the presence or absence of headache concurrent with dyspeptic symptoms.
  • Gastroduodenal mucosal biopsies were analyzed for mast cells, lymphocytes, neutrophils, and enteroendocrine cells.

Main Results:

  • Headache was not significantly associated with lymphocytes, neutrophils, or enteroendocrine cells.
  • A significant association was found between headache and higher mast cell density in both the gastric body and duodenum.
  • Mast cell density was significantly higher in patients with concurrent headaches compared to those without.

Conclusions:

  • Mucosal mast cell density is a key factor associated with headache in pediatric H. pylori-negative functional dyspepsia.
  • These findings offer insights for clinicians managing pediatric patients with co-occurring dyspeptic symptoms and headaches.
  • Targeting mast cell activity may represent a therapeutic approach for headaches in this patient population.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...